abstract |
The invention relates to (i) DNA sequences, (ii) expression vectors, comprising said DNA sequences, (iv) host cells, comprising said expression vectors, (v) genetic products, coded by said sequences, (vi) transgenic animals, altered with regard to said sequences, (vii) antibodies against said genetic products, (viii) method for the expression and isolation of said genetic products, (ix) use of said DNA sequences or genetic products as medicaments, (x) pharmaceutically effective compounds and method for production and use thereof and (xi) non-therapeutic uses of said DNA sequences or genetic products. |